Du et al. (2014) reported that knockdown of c-MET sensitized TRAIL-resistant NB and glioma cell lines to mesenchymal stem cell-delivered secretable form of TRAIL in both an in vitro and in vivo intracranial tumor model. This evidence concerns the gene MET and neuroblastoma.